- Home
- GOSS vs CPS Comparison
GOSS vs CPS Comparison
Compare GOSS & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- CPS
- Stock Information
- Founded
- GOSS 2015
- CPS 1960
- Country
- GOSS United States
- CPS United States
- Employees
- GOSS N/A
- CPS N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- GOSS Health Care
- CPS Consumer Discretionary
- Exchange
- GOSS Nasdaq
- CPS Nasdaq
- Market Cap
- GOSS 212.8M
- CPS 250.0M
- IPO Year
- GOSS 2019
- CPS N/A
- Fundamental
- Price
- GOSS $1.40
- CPS $14.73
- Analyst Decision
- GOSS Strong Buy
- CPS
- Analyst Count
- GOSS 5
- CPS 0
- Target Price
- GOSS $9.20
- CPS N/A
- AVG Volume (30 Days)
- GOSS 1.6M
- CPS 247.3K
- Earning Date
- GOSS 03-04-2025
- CPS 02-13-2025
- Dividend Yield
- GOSS N/A
- CPS N/A
- EPS Growth
- GOSS N/A
- CPS N/A
- EPS
- GOSS N/A
- CPS N/A
- Revenue
- GOSS $105,322,000.00
- CPS $2,730,893,000.00
- Revenue This Year
- GOSS N/A
- CPS $10.95
- Revenue Next Year
- GOSS N/A
- CPS N/A
- P/E Ratio
- GOSS N/A
- CPS N/A
- Revenue Growth
- GOSS N/A
- CPS N/A
- 52 Week Low
- GOSS $0.50
- CPS $11.24
- 52 Week High
- GOSS $1.60
- CPS $19.21
- Technical
- Relative Strength Index (RSI)
- GOSS 67.09
- CPS 48.77
- Support Level
- GOSS $1.37
- CPS $13.85
- Resistance Level
- GOSS $1.55
- CPS $16.21
- Average True Range (ATR)
- GOSS 0.13
- CPS 0.88
- MACD
- GOSS 0.03
- CPS -0.02
- Stochastic Oscillator
- GOSS 75.81
- CPS 56.98
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.